Clinical trials
Phase 3 Atypical Hemolytic Uremic Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 2 |
| 2018 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Alexion Pharmaceuticals, Inc. | 2 |
| Hoffmann-La Roche | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Omeros Corporation | 1 |
| University Hospital, Tours | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atypical Hemolytic Uremic Syndrome | 10 |
| Thrombotic Microangiopathies | 5 |
| Acute Kidney Injury | 1 |
| Glomerulonephritis, Membranoproliferative | 1 |
| Hemolytic-Uremic Syndrome | 1 |
| Hypertensive Crisis | 1 |
| Kidney Diseases | 1 |
| Kidney Failure, Chronic | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.